Inovio Pharmaceuticals: Speculative Buy Thesis Hinges On INO-3107 [Seeking Alpha]
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ:AMEX Investor Relations:
ir.inovio.com/investors/default.aspx
Company Research
Source: Seeking Alpha
INO-3107 targets HPV-6/11 RRP, aiming to reduce repeat surgeries by inducing HPV-specific T-cell responses and addressing the disease's underlying causes. But the FDA questioned INO-3107's accelerated approval. I think this increases the risk of longer timelines with larger confirmatory requirements. This regulatory setback is more concerning because of INO's relatively tight cash runway before being able to monetize INO-3107. Yet, given INO's cheap EV, I think the stock offers asymmetric upside if INO-3107 is approved. That's why I ultimately rate the stock a speculative “buy” today. bymuratdeniz/E+ via Getty Images Inovio Pharmaceuticals, Inc. ( INO ) is a biotechnology company that develops DNA therapeutics for HPV, oncology, and infectious illnesses. The company leverages its CELLECTRA electroporation devices to introduce DNA into cells, allowing the body to produce the desired proteins This article was written by Analyst's Disclosure: I/we have no stock, option or
Show less
Read more
Impact Snapshot
Event Time:
INO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INO alerts
High impacting Inovio Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
INO
News
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INOPR Newswire
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INOGlobeNewswire
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INOGlobeNewswire
- Inovio Pharmaceuticals (NASDAQ:INO) had its "neutral" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- Inovio announces U.S. FDA accepted BLA for INO-3107 [Yahoo! Finance]Yahoo! Finance
INO
Earnings
- 11/10/25 - Miss
INO
Sec Filings
- 12/29/25 - Form 8-K
- 12/8/25 - Form SCHEDULE
- 12/5/25 - Form SCHEDULE
- INO's page on the SEC website